- Telehealth Visits
- Insurance plan information
Amar Nijagal, MD
General Surgery- Telehealth Visits
- Insurance plan information
Amar Nijagal, MD
General Surgery- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Amar Nijagal is a pediatric surgeon who specializes in caring for children with disorders of the liver and bile ducts.
Nijagal runs a research lab that investigates how the immune system affects the development of fetal organs. His research focuses on liver and bile duct development and how changes in the process contribute to congenital diseases.
Nijagal completed his medical degree and a residency in general surgery at UCSF, where he served as chief resident. He completed a postdoctoral research fellowship at the California Institute for Regenerative Medicine and a fellowship in general and thoracic pediatric surgery at Boston Children's Hospital.
Nijagal is a member of the American College of Surgeons, American Pediatric Surgical Association, UCSF Naffziger Surgical Society and Association for Academic Surgery.
Education & training
Board certification
- Pediatric Surgery, American Board of Surgery
- General Surgery, American Board of Surgery
Fellowship
- Pediatric Surgery, Boston Children's Hosp : Pediatric Cardiology
- Pediatric Surgery, Childrens Hospital of Boston - GME
Residency
- General Surgery, UCSF Graduate Medical Education
Internship
- General Surgery, UCSF Graduate Medical Education
Degree
- MD, University of California San Francisco - Registrar
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%221278%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221278%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.